Crescita Therapeutics Inc. (TSE:CTX – Get Free Report) passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$0.61 and traded as low as C$0.59. Crescita Therapeutics shares last traded at C$0.59, with a volume of 9,974 shares.
Crescita Therapeutics Stock Up 5.1 %
The company has a debt-to-equity ratio of 6.02, a quick ratio of 2.29 and a current ratio of 3.37. The company’s 50-day moving average price is C$0.62 and its 200 day moving average price is C$0.50. The stock has a market capitalization of C$12.02 million, a P/E ratio of -3.93 and a beta of 1.71.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
See Also
- Five stocks we like better than Crescita Therapeutics
- How Technical Indicators Can Help You Find Oversold Stocks
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
